Parasitological and clinical efficacy of treatment of ascariasis in children with bioresonance therapy

AUTHORS : Kadochnikova G.V. | Merzlova N.B. | Kolesnik N.V.

RELEVANT UNIVERSITIES : GOU VPO Perm State Medical Academy, Department of Postgraduate Education No. 1, Perm Central District hospital, Perm, Russia

YEAR : 2004 | Category : Research

The urgency of the problem of treatment of ascariasis is to not only in achieve a high parasitological effect and decrease adverse reactions to anthelmintic drugs, but also to achieve clinical recovery in patients. In this regard, it is necessary to use a complex, pathogenetic therapy, taking into account the clinical characteristics of the disease. Recently, the question of including in the complex treatment of non-drug methods of therapy, which are devoid of a number of negative properties of drugs, has been more often raised.

These methods include exogenous bioresonance therapy (EBRT) with fixed frequencies and resonant frequency programs for the treatment of diseases caused by viruses, fungi, protozoa and helminths. The impact on the body is carried out by a low-frequency magnetic field. Until now, this direction in the treatment of helminthiasis has not been studied. Purpose of the study: to conduct a comparative assessment of the parasitological and clinical efficacy of treatment of complex pathogenetic drug therapy and the EBRT method using the example of ascariasis invasion.

Materials and methods

Treatment was carried out to 160 examined children, differentiated, taking into account the stage of the course of the disease. 99 patients were treated with the drug method, of which 15 – with the larval stage and 84 – with the intestinal stage of ascariasis. 61 patients were treated with EBRT, of which 28 had larval and 33 – intestinal ascaris invasion. Complex drug treatment of the migratory stage of ascariasis was carried out using the drug Vermox at a dose of 100 mg 2 times a day for 5 days, regardless of age. The intestinal stage of ascariasis was treated with Vermox (18 children) at a dose of 100 mg 2 times a day for a 3-day course, Pyrantel (45 children) at a dose of 10 mg / kg and Decaris (21 children) at a dose of 2.5 mg / kg once.